Xuecheng Zhang is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Director at Syndax Pharmaceuticals since April 2023. Prior experience includes serving as Executive Director and Director at DermBiont, Inc. from October 2017 to September 2022, and progressing through roles as Sr. Scientist and Scientist at Indigo from March 2015 to October 2017. Xuecheng also gained valuable experience as a Research Fellow at Massachusetts General Hospital and Harvard Medical School between December 2010 and March 2015, and as a Postdoctoral Research Fellow at the University of Missouri from December 2005 to October 2010. Xuecheng Zhang earned a Doctor of Philosophy (Ph.D.) degree from the University of Missouri-Columbia, completing studies from 2000 to 2005.